Implantable Glaucoma Device for Nonpenetrating Trabeculectomy

Glaucoma surgery is a procedure intended to reduce eye pressure in an effort to help stabilize vision and prevent future vision loss resulting from glaucoma. This is accomplished by creating a new opening for fluid to drain from the eye — or, by implanting a shunt to help drain the fluid.

Implantable Glaucoma Device for Nonpenetrating Trabeculectomy Material

Glaucoma Draonage Devices Model FNPT for Glaucoma Surgery is produced biomaterial ethoxyl methacrylate ester/methyl methacrylate copolymer(2-HEMA-co-NMA) which is nontoxic, has no immune response, has good biological compatibility, and cannot be absorbed by tissue. As materials of intraocular lens, it has been clinically applied in ophthalmology for more than ten years, and is universally accepted as good intraocular implantation material by ophthalmology circle.

Characteristics of Implantable Glaucoma Device for Nonpenetrating Trabeculectomy:

1. Raw material: Hydrophilic acrylate. .

2. Which has good biological compatibility, and cannot be absorbed by tissue. .

3. Prohibit the growth of fibrocyte, and prevent the formation of filter channel cicatricle. .

4. To impel the formation of new aqueous humor drainage channel. .

5. Distributary of aqueous humor is formed after the implantation of drainage device.

6. It is safe for long-term usage, and intraocular pressure can be effectively controlled. .

7. To increase the success rate and reliability of Glaucoma operation.

Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. was founded in 1991, is one of the first enterprises in China to produce intraocular lenses and related products. It has introduced advanced American technology and established a complete automated production line, integrating R&D, production, and sales. After 30 years of development, it has become China A benchmark enterprise in the field of intraocular lenses.

Till now, our company has products in sale, such as PMMA Intraocular Lens, Hydrophilic Acrylic Intraocular Lens, Glaucoma Drainage Implants, Hydroxypropyl Methylcellulose, Sodium Hyaluronate, Surgical Suture Needles with Thread, Disposal Injector for Foldable IOL and so on. Over 2 million Universe IOLs has been sold since their launch in 1991, with very low incidences of adverse effects and serious adverse events.

The highest eminence is to be gianed step by step.  Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. will work hard and innovate constantly to improve the quantity of products, elevate the core competitiveness of the enterprise and make even greater contribution to the human health undertaking.